Actively Recruiting
DAta-driven personaLIzation of a digitAl Health Solution to Support Family Caregivers of Children With Chronic Conditions
Led by Adhera Health, Inc. · Updated on 2025-12-01
40
Participants Needed
1
Research Sites
59 weeks
Total Duration
On this page
Sponsors
A
Adhera Health, Inc.
Lead Sponsor
H
Hospital Universitario Miguel Servet, Zaragoza
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this feasibility study is to explore the needs of families with children with obesity and evaluate the impact of a combined intervention (children with obesity receiving pharmacological therapy in combination with the Adhera Caring Digital Program®) on treatment satisfaction, adherence, and mood. The main objectives are: * To evaluate the impact of the treatment combination (ACDP® and pharmacological treatment) in terms of satisfaction, engagement, adherence and mood, in families with children with obesity. * To better understand the educational and support needs of the families of children with obesity while under treatment and lifestyle changes. Participants will: * Use the Adhera Caring Digital Program® (ACDP®) for obesity, which includes digital therapeutic software, personalized messages, and educational materials. * Take pharmacological treatment as prescribed for one year. * Wear activity wristbands/watches to collect biometric data. * Attend monthly clinic visits for assessments and monitoring. * Complete psychometric questionnaires to measure satisfaction, adherence, and emotional outcomes. * Engage in chat-based communication and video conferencing with health coaches for support and monitoring.
CONDITIONS
Official Title
DAta-driven personaLIzation of a digitAl Health Solution to Support Family Caregivers of Children With Chronic Conditions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Caregivers of children aged 13 to 18 years diagnosed with obesity and under approved pharmacological treatment
- Children with obesity treated with orlistat, metformin, liraglutide, or semaglutide before screening
- Willingness to participate in the Adhera Caring Digital Program� for 10 months using a smartphone
- Families agreeing to combine pharmacological treatment with the digital intervention
- Willingness of patients and caregivers to use wearable devices for the entire study duration
- Parents previously using a wearable agree not to use it during the study and to synchronize their account with the patient's device
You will not qualify if you...
- Families not fluent in Spanish
- Children with obesity who have additional medical conditions (comorbidities)
- Children with obesity caused by secondary factors such as hypothalamic, genetic, or endocrine disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Universitario Miguel Servet
Zaragoza, Aragon, Spain, 50009
Actively Recruiting
Research Team
L
Luis Fernadez-Luque, Dr
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here